Search Results - Gavin Cull

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia by Constantine Tam, Javier Munoz, Gavin Cull, Stephen Opat, Heather Allewelt, Xiaoping Zhang, Jennifer C. Stern, James Hilger, Kunthel By, Aileen Cohen, Alessandra Tedeschi

    Published in HemaSphere (2023-04-01)
    Get full text
    Article


  2. 2

    PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-... by Constantine Tam, Mazyar Shadman, Jeff Sharman, Gavin Cull, Tycel Phillips, Judith Trotman, Aileen Cohen, Heather Allewelt, Rocco Crescenzo, Richard Delarue, Heather Zhang, Bilal Tariq, Sri Sahasranaman, Ying C Ou, Ian W Flinn

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  3. 3

    An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement by Andrew J. Sunderland, Raphael E. Steiner, Musa Al Zahrani, Chelsea C. Pinnix, Bouthaina Shbib Dabaja, Jillian R. Gunther, Loretta J. Nastoupil, Mats Jerkeman, David Joske, Gavin Cull, Tarec El‐Galaly, Diego Villa, Chan Yoon Cheah

    Published in Cancer Medicine (2020-01-01)
    Get full text
    Article


  4. 4

    Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients a... by Mark Hertzberg, Maher K. Gandhi, Judith Trotman, Belinda Butcher, John Taper, Amanda Johnston, Devinder Gill, Shir-Jing Ho, Gavin Cull, Keith Fay, Geoff Chong, Andrew Grigg, Ian D. Lewis, Sam Milliken, William Renwick, Uwe Hahn, Robin Filshie, George Kannourakis, Anne-Marie Watson, Pauline Warburton, Andrew Wirth, John F. Seymour, Michael S. Hofman, Rodney J. Hicks

    Published in Haematologica (2017-02-01)
    Get full text
    Article


  5. 5

    How comparable are patient outcomes in the “real-world” with populations studied in pivotal AML trials? by Ing Soo Tiong, Meaghan Wall, Ashish Bajel, Akash Kalro, Shaun Fleming, Andrew W. Roberts, Nisha Thiagarajah, Chong Chyn Chua, Maya Latimer, David Yeung, Paula Marlton, Amanda Johnston, Anoop Enjeti, Chun Yew Fong, Gavin Cull, Stephen Larsen, Glen Kennedy, Anthony Schwarer, David Kipp, Sundra Ramanathan, Emma Verner, Campbell Tiley, Edward Morris, Uwe Hahn, John Moore, John Taper, Duncan Purtill, Pauline Warburton, William Stevenson, Nicholas Murphy, Peter Tan, Ashanka Beligaswatte, Howard Mutsando, Mark Hertzberg, Jake Shortt, Ferenc Szabo, Karin Dunne, Andrew H. Wei, Australasian Leukaemia and Lymphoma Group (ALLG)

    Published in Blood Cancer Journal (2024-03-01)
    Get full text
    Article


Search Tools: